Genetic mapping and predictive modeling of paralog synthetic lethality

Michael J Flister1, Daniel Verduzco1, Sakina Petiwala1

  • 1AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA.

Cell Reports
|November 8, 2025
PubMed

Insights

Synthetic lethality, a potential cancer treatment, is infrequent and varies between tumors. This study identified key features of protein interactions that predict and explain this variability in paralog synthetic lethality.

Area of Science:

  • Genomics
  • Systems Biology
  • Cancer Biology

Background:

  • Paralogous genes are abundant in the human genome and are a potential source of synthetic lethality.
  • The human paralogome remains largely uncharacterized, limiting its therapeutic potential.

Purpose of the Study:

  • To investigate the frequency and penetrance of synthetic lethality in paralogous gene pairs.
  • To identify factors contributing to the variable penetrance of paralog synthetic lethality across different cancer types.

Main Methods:

  • A large-scale digenic screen of 36,648 paralogous pairs in the human genome.
  • Machine learning classification applied to paralog pairs across 49 cancer models.
  • Predictive modeling of synthetic lethal interactions based on protein-protein interaction networks.

Main Results:

  • Synthetic lethalities were infrequent and showed variable penetrance across different tumor backgrounds.
  • Endogenous perturbations in related pathways predicted paralog synthetic lethality.
  • The strength of synthetic lethal interactions correlated with the overlap and essentiality of shared protein-protein interaction networks.

Conclusions:

  • The heterogeneity of paralog synthetic lethality is influenced by complex polygenic interactions and cellular contexts.
  • Understanding protein-protein interaction network properties is crucial for predicting synthetic lethal interactions.
  • This study provides a framework for characterizing the paralogome and exploiting synthetic lethality in cancer therapy.